Implementing Promising Strategies to Reduce the Risk for Viral Hepatitis and Liver Cancer Among People Who Inject

Behnoosh Momin1, Jennifer Mezzo2, Danielle Nielsen2

  • 1Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Abstract

Insights

This project improved awareness of injecting drug risks for viral hepatitis and liver cancer. It successfully implemented strategies to enhance viral hepatitis services and syringe programs in diverse populations.

Area of Science:

  • Public Health
  • Cancer Control
  • Infectious Disease Epidemiology

Background:

  • Injecting drug use is a significant risk factor for viral hepatitis and liver cancer.
  • Comprehensive cancer control programs are essential for addressing health disparities.
  • Effective partnerships are crucial for implementing public health interventions.

Purpose of the Study:

  • To describe a 3-year demonstration project involving Centers for Disease Control and Prevention National Comprehensive Cancer Control Program (NCCCP) award recipients.
  • To build local partnerships to increase awareness of the link between injecting drug use, viral hepatitis, and liver cancer.
  • To improve viral hepatitis service delivery and implement syringe services programs.

Main Methods:

  • A mixed-methods descriptive evaluation was conducted.
  • Four NCCCP award recipients implemented tailored, evidence-based interventions.
  • Processes were monitored, and qualitative interviews assessed challenges and lessons learned.

Main Results:

  • Award recipients implemented key strategies and activities across four main areas.
  • Strong public-private partnerships, technical assistance, and population-specific understanding were critical success factors.
  • Flexibility and a commitment to collaboration facilitated program implementation.

Conclusions:

  • Despite challenges, award recipients successfully implemented vital strategies.
  • Findings support the scaling of best practices for cancer control, particularly for high-risk populations.
  • This project highlights the importance of integrated approaches to address viral hepatitis and cancer risks associated with injecting drug use.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.3K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
879
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
288
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
362
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
60